22nd Century Group’s (XXII) “Sell (E+)” Rating Reiterated at Weiss Ratings

Weiss Ratings reissued their sell (e+) rating on shares of 22nd Century Group (NASDAQ:XXII) in a research report released on Wednesday morning,Weiss Ratings reports.

Separately, StockNews.com cut 22nd Century Group from a “hold” rating to a “sell” rating in a report on Tuesday, December 31st.

22nd Century Group Stock Down 3.1 %

NASDAQ XXII opened at $3.15 on Wednesday. 22nd Century Group has a 12 month low of $3.01 and a 12 month high of $581.85. The company has a market capitalization of $5.42 million, a P/E ratio of 0.00 and a beta of 1.57. The company’s 50 day simple moving average is $4.82 and its 200 day simple moving average is $22.78. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 and a quick ratio of 0.93.

Hedge Funds Weigh In On 22nd Century Group

A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP bought a new position in 22nd Century Group, Inc. (NASDAQ:XXII) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group at the end of the most recent reporting period. 18.06% of the stock is owned by institutional investors.

About 22nd Century Group

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.